Important Safety Information
†Caution - LungFit is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use.
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/07/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
37 |
| 01/23/20 | EFFECT | Notice of Effectiveness |
|
1 | |
| 01/23/20 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
149 | |
| 01/23/20 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
13 | |
| 01/21/20 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 01/21/20 | UPLOAD | SEC-generated letter |
|
1 | |
| 01/17/20 | DEF 14A | Definitive proxy statements |
|
63 | |
| 01/14/20 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
|
168 |
| 12/31/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/20/19 | 8-K | Current report filing |
|
4 |
